Why consumer health spin-out Kenvue climbed in strong market debut
The consumer health spin-out from Johnson & Johnson (JNJ:NYSE), Kenvue (KVUE:NYSE) enjoyed a positive stock market debut on 4 May, with shares in the company surging 22% to $26.90 in a move valuing the business at about $50...
11 May 2023